Kaskela Law LLC announces that it is investigating Viridian Therapeutics, Inc. (NASDAQ: VRDN) (“Viridian”) on behalf of the company’s investors.

The investigation seeks to determine whether Viridian and/or the company’s officers and directors violated the securities laws or breached their fiduciary duties to the company’s shareholders in connection with recent corporate actions.

Viridian shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 – 0750, or by completing the form on this page, for additional information about this investigation and their legal rights and options.